Taipei, July 16 (CNA) The drug permit license for the weight loss drug Belviq has been permanently revoked in Taiwan, the country's Food and Drug Administration (FDA) said Thursday, citing cancer risks.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares open lower
10/04/2023 09:13 AM - Society
Amphetamines disguised as milk powder seized in drug raids
10/03/2023 11:28 PM - Science & Tech
Hon Hai signs MOU with Canadian firm on EV battery development
10/03/2023 10:55 PM - Culture
Malaysian film 'Snow in Midsummer' leads Golden Horse Awards nominations
10/03/2023 10:44 PM - Society
Flights, ferries disrupted as Typhoon Koinu nears
10/03/2023 10:17 PM